Studies on multidrug resistance associated protein in retinoblastoma

Chinese Journal of Ophthalmology

Volumn 45, Issue 4, 2009, Pages 314-317

  Li, Bin ^a   Gao, Rui ^a   Zhang, Hao ^a   Li, Liao Qing ^a   Gao, Fei ^a   Ren, Ruo Jin ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Drung resistance neoplasm; Immunohistochemistry; Lung resistance associated protein; Multidrug resistance associated proteins; P Glycoprotein; Retinoblastoma

Indexed keywords

GLYCOPROTEIN P; TUMOR PROTEIN;

ARTICLE; DRUG RESISTANCE; FEMALE; HUMAN; MALE; METABOLISM; PATHOLOGY; PRESCHOOL CHILD; RETINA TUMOR; RETINOBLASTOMA;

CHILD, PRESCHOOL; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MALE; NEOPLASM PROTEINS; P-GLYCOPROTEIN; RETINAL NEOPLASMS; RETINOBLASTOMA;

EID: 65449176011     PISSN: 04124081     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0412-4081.2009.04.006     Document Type: Article

References (17)

1. Chan HS, Lu Y, Grogan TM, et al. Multidrug resistance protein (MRP) expression in retinoblastoma correlates with the rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein. Cancer Res, 1997, 57: 2325-2330.
2. Pauwels EK, Erba P, Mariani G, et al. Multidrug resistance in cancer: its mechanism and its modulation. Drug News Perspect, 2007, 20:371-377.
3. Higgins CF. Multiple molecular mechanisms for multidrug resistance transporters. Nature, 2007, 446:749-757.
4. Helson L, Kitchin FD, Abramson D, et al. Metastatic retinoblastoma and L-phenylalanine mustard-dianhydrogalactitol. Anticancer Res, 1982,2:235-238.
5. Chan HS, Thorner PS, Haddad G, et al. Multidrug-resistant phenotype in retinoblastorna correlates with P-glycoprotein expression. Ophthalmology, 1991,98:1425-1431.
6. Verrelle P, Meissonnier F, Fonch Y, et al. Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma. J Natl Cancer Inst, 1991, 83: 111-116.
7. Aszalos A. Mechanism of multidrug recognition by MDR1/ABCB1. ABCB1. Cancer Sci, 2007, 98:1303-1310.
8. Wang BL, Zhai HY, Chen BY, et al. Clinical relationship between MDR1 gene and gallbladder cancer. Hepatobiliary Pancreat Dis Int, 2004, 3:296-299.
9. Salama NN, Yang Z, Bui T, et al. MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells. J Pharm Scl, 2006, 95: 2293-2308.
10. Yeh JJ, Hsu WH, Wang JJ, et al. Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell. lung cancer with P-glycoprotein expression. Respriation, 2003, 70:32-35.
11. Chinese source.
12. Scheffer CL, Wijngaard PL, Flens MJ, et al. The drug resistance-related protein LRP is the human major vault protein. Nature Med, 1995,1: 578-582.
13. Scheffer GL, Schroeijers AB, Izquierdo MA, et al. Lung resistance-related protein/Major vault protein and vaults in multidrug resistance cancer. Cuff Opin Oncol, 2000, 12: 550-556.
14. Bordow SB, Haber M, Madafiglio J, et al. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res, 1994,54:5036-5040.
15. Chinese source.
16. Chinese source.
17. Brotherick I, Shenton BK, Egan M, et al. Examination of multidrug resistance in cell lines and primary breast tumours by flow cytometry. Eur J Cancer, 1996, 32A:2334-2341.